NNNN
Anbio Biotechnology
3월 13일 4:00 PM ET (한국 3/14 05:00)
$20.51
-2.03 ▼ -9.01%
🌙 3월 13일 5:44 PM ET (한국 3/14 06:44)
$21.17
+0.66 ▲ +3.22%
| Index | - | P/E | 324.53 | EPS (ttm) | 0.06 | Insider Own | 9.57% | Shs Outstand | 0.04B | Perf Week | -10.4% |
| Market Cap | 2.95B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.04B | Perf Month | -24.48% |
| Enterprise Value | 2.94B | PEG | - | EPS next Q | - | Inst Own | 0.07% | Short Float | 0.12% | Perf Quarter | -35.65% |
| Income | 0.00B | P/S | 391.41 | EPS this Y | - | Inst Trans | -1.78% | Short Ratio | 0.83 | Perf Half Y | -52.93% |
| Sales | 0.01B | P/B | 27.84 | EPS next 5Y | - | ROA | 10.7% | Short Interest | 0.05M | Perf YTD | -31.79% |
| Book/sh | 0.74 | P/C | 187.26 | EPS past 3/5Y | -5.05% - | ROE | 10.84% | 52W High | -63.14% ($55.65) | Perf Year | 201.17% |
| Cash/sh | 0.11 | P/FCF | 1311.65 | Sales past 3/5Y | 19.15% - | ROIC | 8.73% | 52W Low | 248.22% ($5.89) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | 1513.12 | EPS Y/Y TTM | -42.91% | Gross Margin | 89.72% | Volatility(W/M) | 10.14% 10.54% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 389.32 | Sales Y/Y TTM | -26.65% | Oper. Margin | 25.78% | ATR (14) | 3.14 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 211.1 | EPS Q/Q | 2.83% | Profit Margin | 37.47% | RSI (14) | 41.07 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 211.1 | Sales Q/Q | -20.8% | SMA20 | -13.72% ($23.77) | Beta | 9.83 | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | -23.79% ($26.91) | Rel Volume | 0.68 | Prev Close | $22.54 |
| Employees | 27 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -34.59% ($31.36) | Avg Volume(3M) | 0.06M | Price | $20.51 |
| IPO | 2025/2/19 | Option/Short | No/Yes | Trades | 794 | Volume | 40,454 | Change | -9.01% |
뉴스 로딩 중...